Harnessing the Latest Advances to Preserve and Improve Cognitive Function in MS
Harnessing the Latest Advances to Preserve and Improve Cognitive Function in MS is organized by Prime Education, LLC.
Release Date: March 29, 2023
Expiration Date: June 28, 2024
Description:
Significant advances in multiple sclerosis (MS) treatment have paved the way for patients to live long, healthy lives. However, a significant proportion of patients experience the debilitating symptoms of MS, including cognitive impairment, which is often underassessed and, therefore, suboptimally managed. Cognitive impairment occurs at all stages of MS and is unlikely to remit and more likely to progress, which in turn can have a substantial impact on patients' vocational ability, social interactions, and quality of life. Recent evidence demonstrates that certain disease modifying therapies are associated with a reduction in brain atrophy and cognitive impairment. This evidence, along with patients' clinical characteristics, preferences, and goals should be integrated into treatment selection and management decisions in order to maximize outcomes.
Tune in and take an in-depth look at:
• The impact of cognitive deficits on quality of life, work productivity, and daily functioning for people living with MS
• Evidence-based strategies to perform regular cognitive assessments
• The latest clinical data on disease-modifying therapies (DMTs) and their effects on preserving brain volume and cognitive performance
• Practical approaches to shared decision-making that ensure that MS treatment plans align with patients' individual goals, preferences, and needs, including those pertaining to cognitive function
Agenda:
• Overview of the Impact and Burden of Cognitive Impairment in Patients With MS
• Incorporating Validated Tools for Cognitive Assessment Into Routine Clinical Practice
• Latest Clinical Trial Data on Brain Volumes and Cognitive Outcomes With Novel DMTs: Implications for Treatment Planning and DMT Selection
• Strategies to Incorporate Shared Decision-Making in the Development of Personalized MS Treatment Plans
Learning Objectives:
• Apply evidence-based tools and strategies for assessing and monitoring cognitive function in patients with MS to support early recognition of cognitive impairment
• Evaluate the latest clinical data on disease-modifying therapies (DMTs) and their efficacy in preserving brain volume and improving cognitive outcomes
• Incorporate leading strategies for engaging patients in shared decision-making to ensure that MS treatment plans align with patients' individual goals and preferences